Hoka's Skyward X 2 is now a week beyond its 15 May launch, with both the £195 UK release and the $225 US drop landing into a reviewer landscape that is markedly warmer than the original's. The opening tranche of long-form video and written reviews — Doctors of Running, Road Trail Run, Believe in the Run, Tom's Guide, Alastair Running — line up on a tighter, more aggressive ride than the 2024 debut, helped most obviously by the 0.8oz weight cut in men's sizes and a full ounce off the women's last. Hoka now offers proper wide D and extra-wide 2E options in men's sizing, a quiet but pointed acknowledgement that the original Skyward X's narrow forefoot was the single most-flagged complaint of its first year on shelves.
The midsole architecture survives largely intact: a PEBA top layer above the carbon-fibre wing-plate, with a supercritical EVA chassis underneath to hold the geometry in check. Hoka has shaved the stack roughly 2mm from heel and forefoot to bring the shoe inside the 40mm World Athletics ceiling more comfortably, while the plate itself has been reshaped to sit a touch closer to the ground in the forefoot. Reviewers have all noted the more engaged toe-off and have largely agreed that the X 2 finally delivers the propulsive ride the original promised, with both Doctors of Running and Road Trail Run describing the shoe as 'a clear upgrade' over its predecessor.
The upper has been pulled back to a single-layer premium jacquard mesh with a reinforced midfoot saddle and a less-padded gusseted tongue. Most reviewers have called the fit improvement the bigger story than the midsole tweaks: where the original's narrow toebox forced runners up half a size, the X 2's true-to-size build has held through 30-mile and 80-mile review windows. Hoka has retained the divisive notched heel collar but softened its internal foam, which has cut down on Achilles bite complaints. The outsole still uses the original X's segmented rubber pattern, with reviewers warning that wear has been visible inside 60 miles of marathon-pace work — typical for the category but worth flagging for the £195 outlay.
Hoka positions the X 2 as a daily trainer with race-day capability, not a pure racer, and most reviewers have settled on that framing. The supercritical EVA chassis still holds the shoe back from the snappy pop of an Alphafly 4 or Adios Pro Evo 3, and at 268g in a men's UK 9 it remains heavier than the carbon-plate racers Hoka has stacked at the top of its 2026 line. The pitch is for the runner who wants one shoe that can handle 80 per cent of weekly mileage, including marathon pace, without owning a separate race-day tool. Several reviewers have flagged it as the right choice for Ironman and middle-distance triathletes for that reason.
The broader retail rollout is now nearly complete, with Run Specialty stores in the UK, Germany, France and the US carrying the X 2 in five colourways as of Friday and a sixth Tokyo-only colour scheduled for early June. Hoka has hinted that an X 2 LE colourway will be released ahead of the autumn marathon majors, with a Berlin-themed makeup the worst-kept secret in the running media. The shoe's bigger commercial question — whether Hoka can claw back its share of the super-trainer market from Nike's Vomero Premium and Adidas's reissued Adios Pro Evo line — will be answered through the second half of the year, but the X 2's launch is the most confident step Hoka has taken in that direction since the Cielo X1 dropped in early 2024.